A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA.
about
Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and OsteoblastsRole for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma.Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients.Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene (NR3C1).Targeting the pro-survival protein MET with tivantinib (ARQ 197) inhibits growth of multiple myeloma cells.Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models.Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implicationsStatins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activationInhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBPMicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesGrowth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cellsDNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.Gene integrated set profile analysis: a context-based approach for inferring biological endpointsIdentification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro.Targeting executioner procaspase-3 with the procaspase-activating compound B-PAC-1 induces apoptosis in multiple myeloma cells.Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease.Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cellsEffect of cAMP signaling on expression of glucocorticoid receptor, Bim and Bad in glucocorticoid-sensitive and resistant leukemic and multiple myeloma cells.Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.
P2860
Q28551480-0E7F29CE-ED87-45F8-9F34-E977E5AD7F1BQ34200686-771E8E48-5170-49C3-9335-3540A5241648Q34410261-DA4A77AE-31BE-49ED-940D-AAFA065B7938Q35002526-9BA9607D-CCF8-4903-B389-02CC3EF822EAQ35214544-46A3ED0E-9EAE-4206-A964-D49E3437762CQ35402899-1F9323D1-2FE6-4926-8FB4-20906498F2FCQ35734509-A39F454D-FD98-4690-A4C7-955408FFC4B9Q35828643-7B6E8B7F-E5BB-4B10-8263-3297C85D9A87Q36447976-7C4B4451-1455-4CA3-BAEC-F035705E15BAQ36602853-03A13EAE-407E-41DA-9321-2A64B39899F6Q36952838-3705710B-A449-45D5-A761-D3EFF805D2C3Q37129624-EEB0B4DD-D11C-4B34-AFE2-9C90ECB661E4Q37505517-82C204FD-B339-40EB-B77D-1F3A36A58DDBQ38798005-4DDA980C-7026-4A86-85A6-F5ADEB28A45EQ38808084-B8C20B58-E3A8-4F11-831C-1BB9BF0225B8Q40359915-5C9FA1EF-601B-45D8-BBEE-75930A5ACF4EQ40643079-183931F1-7038-4A0B-8F37-561C25CBC407Q40742165-19177BD8-2C4D-4A39-BB72-A485FD0888E6Q42156460-177FD9F6-9FA1-4ABC-A066-23B226BE2468Q43225747-505E77C0-A56B-4426-872D-3BD9FB281F4EQ46319985-EDB52689-82B6-40B9-A1B0-BFE589CE26C2
P2860
A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
A mechanism of resistance to g ...... glucocorticoid receptor mRNA.
@en
A mechanism of resistance to g ...... glucocorticoid receptor mRNA.
@nl
type
label
A mechanism of resistance to g ...... glucocorticoid receptor mRNA.
@en
A mechanism of resistance to g ...... glucocorticoid receptor mRNA.
@nl
prefLabel
A mechanism of resistance to g ...... glucocorticoid receptor mRNA.
@en
A mechanism of resistance to g ...... glucocorticoid receptor mRNA.
@nl
P2093
P1433
P1476
A mechanism of resistance to g ...... glucocorticoid receptor mRNA.
@en
P2093
P304
P407
P577
1992-01-01T00:00:00Z